Does KPV affect skin tanning like alpha-MSH?

No. KPV is the C-terminal fragment of alpha-MSH and retains anti-inflammatory activity but lacks the melanocortin pigmentation pharmacophore, so it does not stimulate tanning.

Why is KPV often paired with BPC-157 for gut research?

BPC-157 is studied for mucosal repair and angiogenesis while KPV targets NF-kB-driven inflammation, so researchers combine them to address both healing and inflammatory components of gut models.

← All peptides

Healing & Recovery

Immune

Preclinical

KPV

Also known as: KPV, Lysine-Proline-Valine

KPV is a tripeptide derived from the C-terminus of alpha-MSH that exerts anti-inflammatory effects without pigmentary activity. It is studied for gut inflammation, wound healing, and skin conditions.

Mechanism of Action

KPV corresponds to the alpha-MSH(11-13) sequence and acts as an anti-inflammatory peptide that can enter cells and reach the nucleus to inhibit NF-kB activation, dampening transcription of pro-inflammatory cytokines such as TNF-alpha and IL-6. It also interacts with the intestinal peptide transporter PepT1 on epithelial and immune cells, concentrating its action in inflamed gut tissue. Unlike full-length alpha-MSH, KPV lacks the core melanocortin pharmacophore, so it provides immunomodulation without stimulating melanocyte pigmentation.

Half-life: Short, estimated under 1 hour for the free tripeptide
Administration Routes: subcutaneous, oral, topical
Research Status: Preclinical